• 1
    Coello MC, Luketich JD, Litle VR, et al. Prognostic significance of micrometastasis in non-small-cell lung cancer. Clin Lung Cancer. 2004; 5: 214-225.
  • 2
    Nakamori S, Kameyama M, Imaoka S, et al. Increased expression of sialyl Lewisx antigen correlates with poor survival in patients with colorectal carcinoma: clinicopathological and immunohistochemical study. Cancer Res. 1993; 53: 3632-3637.
  • 3
    Izumi Y, Kawamura YJ, Irimura T. Carbohydrate antigens in carcinoma invasion and metastasis. Nippon Geka Gakkai Zasshi. 1996; 97: 140-144.
  • 4
    Ogawa JI, Inoue H, Koide S. Alpha-2,3-sialyltransferase type 3N and alpha-1,3-fucosyltransferase type VII are related to sialyl Lewis(x) synthesis and patient survival from lung carcinoma. Cancer. 1997; 79: 1678-1685.
  • 5
    Foxall C, Watson SR, Dowbenko D, et al. The 3 members of the selectin receptor family recognize a common carbohydrate epitope, the sialyl Lewis (x) oligosaccharide. J Cell Biol. 1992; 117: 895-902.
  • 6
    Mantovani A, Sozzani S, Locati M, et al. Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol. 2002; 23: 549-555.
  • 7
    Chen JJ, Yao PL, Yuan A, et al. Up-regulation of tumor interleukin-8 expression by infiltrating macrophages: its correlation with tumor angiogenesis and patient survival in non-small cell lung cancer. Clin Cancer Res. 2003; 9: 729-737.
  • 8
    Toomey D, Smyth G, Condron C, et al. Infiltrating immune cells, but not tumour cells, express FasL in non-small cell lung cancer: no association with prognosis identified in 3-year follow-up. Int J Cancer. 2003; 103: 408-412.
  • 9
    Fridlender ZG, Sun J, Kim S, et al. Polarization of tumor-associated neutrophil phenotype by TGF-beta: “N1” versus “N2” TAN. Cancer Cell. 2009; 16: 183-194.
  • 10
    Bellocq A, Antoine M, Flahault A, et al. Neutrophil alveolitis in bronchioloalveolar carcinoma: induction by tumor-derived interleukin-8 and relation to clinical outcome. Am J Pathol. 1998; 152: 83-92.
  • 11
    Welch DR, Schissel DJ, Howrey RP, et al. Tumor-elicited polymorphonuclear cells, in contrast to “normal” circulating polymorphonuclear cells, stimulate invasive and metastatic potentials of rat mammary adenocarcinoma cells. Proc Natl Acad Sci U S A. 1989; 86: 5859-5863.
  • 12
    Schwartz JD, Monea S, Marcus SG, et al. Soluble factor(s) released from neutrophils activates endothelial cell matrix metalloproteinase-2. J Surg Res. 1998; 76: 79-85.
  • 13
    Muhs BE, Plitas G, Delgado Y, et al. Temporal expression and activation of matrix metalloproteinases-2,-9, and membrane type 1-matrix metalloproteinase following acute hindlimb ischemia. J Surg Res. 2003; 111: 8-15.
  • 14
    Tazawa H, Okada F, Kobayashi T, et al. Infiltration of neutrophils is required for acquisition of metastatic phenotype of benign murine fibrosarcoma cells: implication of inflammation-associated carcinogenesis and tumor progression. Am J Pathol. 2003; 163: 2221-2232.
  • 15
    Wislez M, Antoine M, Rabbe N, et al. Neutrophils promote aerogenous spread of lung adenocarcinoma with bronchioloalveolar carcinoma features. Clin Cancer Res. 2007; 13: 3518-3527.
  • 16
    Leibovich SJ, Polverini PJ, Shepard HM, et al. Macrophage-induced angiogenesis is mediated by tumour necrosis factor-alpha. Nature. 1987; 329: 630-632.
  • 17
    Kuninaka S, Yano T, Yokoyama H, et al. Direct influences of pro-inflammatory cytokines (IL-1beta, TNF-alpha, IL-6) on the proliferation and cell-surface antigen expression of cancer cells. Cytokine. 2000; 12: 8-11.
  • 18
    St. Hill CA, Alexander SR, Walcheck B. Indirect capture augments leukocyte accumulation on P-selectin in flowing whole blood. J Leukoc Biol. 2003; 73: 464-471.
  • 19
    St. Hill CA, Farooqui M, Mitcheltree G, et al. The high affinity selectin glycan ligand C2-O-sLex and mRNA transcripts of the core 2 beta-1,6-N-acetylglucosaminyltransferase (C2GnT1) gene are highly expressed in human colorectal adenocarcinomas [serial online]. BMC Cancer. 2009; 9: 79.
  • 20
    Balkwill F. Tumor necrosis factor and cancer. Nat Rev Cancer. 2009; 9: 361-371.
  • 21
    Ishibashi Y, Inouye Y, Okano T, et al. Regulation of sialyl-Lewis X epitope expression by TNF-alpha and EGF in an airway carcinoma cell line Glycoconj J. 2005; 22: 53-62.
  • 22
    Pinto CA, Carvalho PE, Antonangelo L, et al. Morphometric evaluation of tumor matrix metalloproteinase 9 predicts survival after surgical resection of adenocarcinoma of the lung. Clin Cancer Res. 2003; 9: 3098-3104.
  • 23
    Guo CB, Wang S, Deng C, et al. Relationship between matrix metalloproteinase 2 and lung cancer progression. Mol Diagn Ther. 2007; 11: 183-192.
  • 24
    Sasaki K, Kurata K, Funayama K, et al. Expression cloning of a novel a(1,3)-fucosyltransferase that is involved in biosynthesis of the sialyl Lewis x carbohydrate determinants in leukocytes. J Biol Chem. 1994; 269: 14730-14737.
  • 25
    Sasaki K, Watanabe E, Kawashima K, et al. Expression cloning of a novel Gal beta (1-3/1-4) GlcNAc alpha 2,3-sialyltransferase using lectin resistance selection. J Biol Chem. 1993; 268: 22782-22787.
  • 26
    Togayachi A, Kudo T, Ikehara Y, et al. Up-regulation of Lewis enzyme (Fuc-TIII) and plasma-type a1,3fucosyltransferase (Fuc-TVI) expression determines the augmented expression of sialyl Lewis X antigen in non-small cell lung cancer. Int J Cancer. 1999; 83: 70-79.
  • 27
    Houghton AM. The paradox of tumor-associated neutrophils: fueling tumor growth with cytotoxic substances. Cell Cycle. 2010; 9: 1732-1737.
  • 28
    Takanami I, Takeuchi K, Gika M. Immunohistochemical detection of eosinophilic infiltration in pulmonary adenocarcinoma. Anticancer Res. 2002; 22: 2391-2396.